• Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery.
  • Cataracts are one of the leading causes of vision impairment. Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.
  • Over half a million eyes worldwide have already experienced clearer, extended range of vision with TECNIS PureSee IOL after cataract surgery.
  • 97% of patients would recommend TECNIS PureSee IOL to friends or family.

Johnson & Johnson (NYSE:JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is an extended depth of focus (EDOF) lens designed to support visual clarity and quality for patients undergoing cataract surgery.